News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>HENGRUI PHARMA (01276.HK) IPO Starts Tdy; 1-lot Entry Fee $8,898.85
Chinese innovative pharmaceutical company, HENGRUI PHARMA (01276.HK), announced its IPO details, proposing to offer 225 million shares globally, with Hong Kong public offering acco...
Reset
Send
The window will close in 5 seconds
<IPO>HENGRUI PHARMA (01276.HK) IPO Starts Tdy; 1-lot Entry Fee $8,898.85
Close
Recommend
16
Positive
23
Negative
9
 
SHORT SELL
 
STOCK INFO

Chinese innovative pharmaceutical company, HENGRUI PHARMA (01276.HK), announced its IPO details, proposing to offer 225 million shares globally, with Hong Kong public offering accounting for 12.3486 million shares and international offering for 212 million shares.

The offer price per share ranges from $41.45 to $44.05. Based on 200 shares per board lot, the entry fee for one board lot is $8,898.85. The IPO starts today (15th) and will close at noon next Tuesday (20th), with the shares expected to be listed next Friday (23rd). The joint sponsors are Morgan Stanley, Citi Research and Huatai International.

Related NewsBOCOMI: CATL's HK IPO Price Cap Offers Limited Discount vs A-Shrs; A/H Listing to Woo Domestic, Foreign Capital
The company introduced seven cornerstone investors, including GIC, Invesco Advisers, UBS AM Singapore, Cordial Solar, Hillhouse, Millennium and Oaktree, which subscribed a total of US$533 million (approx. $4.131 billion) worth of shares.
(HK stocks quote is delayed for at least 15 mins.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.